The question bank is the fastest way to start, but PMHNP Helper also includes board-review planning, student resources, and plain-English guidance for psychiatric nurse practitioner students who are still learning the exam landscape.
A 40-year-old female with recurrent major depressive disorder and comorbid avoidant personality traits has been receiving interpersonal therapy (IPT) for 16 sessions over five months. Her PHQ-9 has fluctuated between 13 and 16 throughout treatment with no sustained improvement from her baseline of 15. She attends sessions consistently and is engaged in the therapeutic process, but she continues to endorse persistent feelings of inadequacy, avoidance of social relationships due to fear of rejection, and rigid self-critical thought patterns. The therapist notes that while the patient has gained insight into her interpersonal patterns, she has difficulty translating this insight into behavioral change. Her interpersonal functioning has not measurably improved based on the Inventory of Interpersonal Problems (IIP) scores. The PMHNP is evaluating psychotherapy treatment progress and considering whether a modality change is indicated. Which evaluation is most appropriate?
Explanation
Evaluating psychotherapy progress requires tracking validated outcome measures over an adequate treatment course and recognizing when a modality is not producing expected gains. When a patient demonstrates nonresponse to one evidence-based psychotherapy after an adequate trial, the evaluation should consider whether an alternative modality with different therapeutic mechanisms would better target the identified maintaining factors, rather than simply extending ineffective treatment or abandoning psychotherapy altogether.
Key Takeaway
Psychotherapy modality changes should be evaluated when validated outcome measures show no improvement after an adequate trial, with the alternative modality selected based on its alignment with the specific cognitive, behavioral, or interpersonal factors maintaining the patient's symptoms.